key: cord-0900367-bgmm8x9s authors: Prestel, Christopher; Anderson, Erica; Forsberg, Kaitlin; Lyman, Meghan; de Perio, Marie A.; Kuhar, David; Edwards, Kendra; Rivera, Maria; Shugart, Alicia; Walters, Maroya; Dotson, Nychie Q. title: Candida auris Outbreak in a COVID-19 Specialty Care Unit — Florida, July–August 2020 date: 2021-01-15 journal: MMWR Morb Mortal Wkly Rep DOI: 10.15585/mmwr.mm7002e3 sha: b5a2e3729941a1937599a10b9c8b7fe37e07f735 doc_id: 900367 cord_uid: bgmm8x9s In July 2020, the Florida Department of Health was alerted to three Candida auris bloodstream infections and one urinary tract infection in four patients with coronavirus disease 2019 (COVID-19) who received care in the same dedicated COVID-19 unit of an acute care hospital (hospital A). C. auris is a multidrug-resistant yeast that can cause invasive infection. Its ability to colonize patients asymptomatically and persist on surfaces has contributed to previous C. auris outbreaks in health care settings (1-7). Since the first C. auris case was identified in Florida in 2017, aggressive measures have been implemented to limit spread, including contact tracing and screening upon detection of a new case. Before the COVID-19 pandemic, hospital A conducted admission screening for C. auris and admitted colonized patients to a separate dedicated ward. Among patients screened who had available medical records (20), two (10%) were admitted directly from a long-term care facility and eight (40%) died within 30 days of screening, but whether C. auris contributed to death is unknown (Table) . HCP in the COVID-19 unit were observed wearing multiple layers of gowns and gloves during care of COVID-19 patients. HCP donned eye protection, an N95 respirator, a cloth isolation gown, gloves, a bouffant cap, and shoe covers on entry to the COVID-19 unit; these were worn during the entire shift. A second, disposable isolation gown and pair of gloves were donned before entering individual patient rooms, then doffed and discarded upon exit. Alcohol-based hand sanitizer was used on gloved hands after doffing outer gloves. HCP removed all PPE and performed hand hygiene before exiting the unit. Investigators observed multiple opportunities for contamination of the base layer of gown and gloves during doffing and through direct contact with the patient care environment or potentially contaminated surfaces such as mobile computers. Mobile computers and medical equipment were not always disinfected between uses, medical supplies (e.g., oxygen tubing and gauze) were stored in open bins in hallways and accessed by HCP wearing the base PPE layer, and missed opportunities for performing hand hygiene were observed. A combination of factors that included HCP using multiple gown and glove layers in the COVID-19 unit, extended use of the underlayer of PPE, lapses in cleaning and disinfection of shared medical equipment, and lapses in adherence to hand hygiene likely contributed to widespread C. auris transmission. After hospital A removed supplies from hallways, enhanced cleaning and disinfection practices, and ceased base PPE layer practices, no further C. auris transmission was detected on subsequent surveys. The COVID-19 pandemic has prompted facilities to implement PPE conservation strategies during anticipated or existing shortages and to use PPE in ways that are not routine (e.g., extended wear and reuse) (8) . Some health care facilities not experiencing shortages allow extra PPE layers because of the perception of increased protection for HCP. CDC does not recommend the use of more than one isolation gown or pair of gloves at a time when providing care to patients with suspected or confirmed SARS-CoV-2 infection (9,10). Such practices among HCP might be motivated by fear of becoming infected with SARS-CoV-2 but instead might increase risks for self-contamination when doffing and for transmission of other pathogens among patients and exacerbate PPE supply shortages. When managing SARS-CoV-2 patients in a dedicated ward, HCP should maintain standard practices (e.g., hand hygiene at indicated times and recommended cleaning and disinfection) intended to prevent transmission of other pathogens. †, § Outbreaks such as that described in this report highlight the importance of adhering to recommended infection control and PPE practices and continuing surveillance for novel pathogens like C. auris. † https://www.cdc.gov/infectioncontrol/guidelines/index.html. § https://www.cdc.gov/coronavirus/2019-ncov/hcp/infection-control.html. GA: US Department of Health and Human Services, CDC Notes from the field: ongoing transmission of Candida auris in health care facilities-United States Investigation of the first seven reported cases of Candida auris, a globally emerging invasive, multidrugresistant fungus-United States First report of Candida auris in America: Clinical and microbiological aspects of 18 episodes of candidemia Multidrug-resistant Candida auris infections in critically ill coronavirus disease patients Survival, persistence, and isolation of the emerging multidrug-resistant pathogenic yeast Candida auris on a plastic health care surface Candida auris Investigation Workgroup. Candida auris in healthcare facilities COVID-19): optimizing supply of PPE and other equipment during shortages COVID-19): strategies for optimizing the supply of isolation gowns COVID-19): strategies for optimizing the supply of disposable medical gloves All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. No potential conflicts of interest were disclosed.